Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Asha Multani"'
Autor:
Melissa M Singh, Adrienne Howard, Mary E Irwin, Yin Gao, Xiaolin Lu, Asha Multani, Joya Chandra
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51611 (2012)
The BCR-ABL1 oncogene is a tyrosine kinase that activates many signaling pathways, resulting in the induction of chronic myeloid leukemia (CML). Kinase inhibitors, such as imatinib, have been developed for the treatment of CML; however, the terminal,
Externí odkaz:
https://doaj.org/article/ed0cff22051b49f38527f7a4e0f4f26c
Autor:
Dimpy Koul, W.K. Alfred Yung, Tim P. Heffernan, John F. de Groot, Roel G. Verhaak, Erik P. Sulman, Asha Multani, Ningping Feng, Xiaolong Li, Jie Ding, Ravesanker Ezhilarasan, Emmanuel Martinez-Ledesma, Chen Zhang, Siyuan Zheng, Feng Gao, Shaofang Wu
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67555cd1814e814e6044b030bade2038
https://doi.org/10.1158/1078-0432.22478232.v1
https://doi.org/10.1158/1078-0432.22478232.v1
Autor:
Dimpy Koul, W.K. Alfred Yung, Tim P. Heffernan, John F. de Groot, Roel G. Verhaak, Erik P. Sulman, Asha Multani, Ningping Feng, Xiaolong Li, Jie Ding, Ravesanker Ezhilarasan, Emmanuel Martinez-Ledesma, Chen Zhang, Siyuan Zheng, Feng Gao, Shaofang Wu
Purpose:Exploration of novel strategies to extend the benefit of PARP inhibitors beyond BRCA-mutant cancers is of great interest in personalized medicine. Here, we identified EGFR amplification as a potential biomarker to predict sensitivity to PARP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee51bd0b213f36ec09585303dd670d1
https://doi.org/10.1158/1078-0432.c.6529896.v1
https://doi.org/10.1158/1078-0432.c.6529896.v1
Autor:
Dimpy Koul, W.K. Alfred Yung, Tim P. Heffernan, John F. de Groot, Roel G. Verhaak, Erik P. Sulman, Asha Multani, Ningping Feng, Xiaolong Li, Jie Ding, Ravesanker Ezhilarasan, Emmanuel Martinez-Ledesma, Chen Zhang, Siyuan Zheng, Feng Gao, Shaofang Wu
Supplemental Figures and legends for Figure S1-S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35025ad4851028f82c1aedddbe1a186d
https://doi.org/10.1158/1078-0432.22478235
https://doi.org/10.1158/1078-0432.22478235
Autor:
Maitri Y, Shah, Manuela, Ferracin, Valentina, Pileczki, Baoqing, Chen, Roxana, Redis, Linda, Fabris, Xinna, Zhang, Cristina, Ivan, Masayoshi, Shimizu, Cristian, Rodriguez-Aguayo, Mihnea, Dragomir, Katrien, Van Roosbroeck, Maria Ines, Almeida, Maria, Ciccone, Daniela, Nedelcu, Maria Angelica, Cortez, Taghi, Manshouri, Steliana, Calin, Muharrem, Muftuoglu, Pinaki P, Banerjee, Mustafa H, Badiwi, Jan, Parker-Thornburg, Asha, Multani, James William, Welsh, Marcos Roberto, Estecio, Hui, Ling, Ciprian, Tomuleasa, Delia, Dima, Hui, Yang, Hector, Alvarez, M James, You, Milan, Radovich, Elizabeth, Shpall, Muller, Fabbri, Katy, Rezvani, Leonard, Girnita, Ioana, Berindan-Neagoe, Anirban, Maitra, Srdan, Verstovsek, Riccardo, Fodde, Carlos, Bueso-Ramos, Mihai, Gagea, Guillermo Garcia, Manero, George A, Calin
Publikováno v:
Genome research. 28(4)
The cancer-risk-associated rs6983267 single nucleotide polymorphism (SNP) and the accompanying long noncoding RNA CCAT2 in the highly amplified 8q24.21 region have been implicated in cancer predisposition, although causality has not been established.
Autor:
Jianchun Xu, Ruoxiang Wang, Zhi Hui Xie, Valerie Odero‐Marah, Sen Pathak, Asha Multani, Leland W.K. Chung, Haiyen E. Zhau
Publikováno v:
Prostate; Nov2006, Vol. 66 Issue 15, p1664-1673, 10p